Frontlight ResearchEarly access
Trial site
Azienda Ospedaliero - Universitaria di Ferrara
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia1 trial
- Coeliac disease1 trial
- Coronary artery disease1 trial
- Lung cancer1 trial
- Metastatic breast cancer1 trial
- Myelodysplastic syndromes1 trial
- Psoriasis1 trial
- Phase
- Phase 22 trials
- Phase 32 trials
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Withdrawn1 trial
- Lead sponsor
- Amgen1 trial
- CoreAalst BV1 trial
- Eli Lilly and Company1 trial
- Janssen Research & Development, LLC1 trial
- Janssen-Cilag S.p.A.1 trial
- and 1 more
Running trials
Active, not recruiting
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
Active, not recruiting
Active, not recruiting
Closed trials
Completed
Withdrawn
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026